Prevalence of Mollicutes among men who have sex with men and transgender women aged 15 to 19 years in Salvador, North-eastern Brazil.
Mollicutes
Mycoplasma
PrEP
Prevalence
STI
Ureaplasma
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
18 Apr 2023
18 Apr 2023
Historique:
received:
15
08
2022
accepted:
31
03
2023
medline:
20
4
2023
pubmed:
19
4
2023
entrez:
18
04
2023
Statut:
epublish
Résumé
Some species of Mollicutes have been associated with different pathologies of the urogenital tract in humans, with a high prevalence among adult men who have sex with men (MSM) and transgender women (TGW). However, few studies have been performed to investigate its prevalence among adolescents. In this study, we estimated the initial prevalence of Mycoplasma genitalium (MG), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), and Ureaplasma parvum (UP); the rate of misdiagnosis at different anatomical sites; and the associated factors with positive tests for Mollicutes among MSM and TGW aged 15 to 19 years enrolled in the PrEP1519 study. PrEP-1519 is the first study to investigate the effectiveness of pre-exposure prophylaxis for human immunodeficiency virus among adolescent MSM and TGW aged 15 to 19 in Latin America. Oral, anal, and urethral swabs were taken from 246 adolescents upon enrolment in the study to detect MG, MH, UU, and UP by quantitative polymerase chain reaction (qPCR). Bivariate and multivariate analyses were conducted by Poisson regression and 95% confidence intervals (95% CI) were estimated. The prevalence of Mollicutes was 32.1%. UU was the most prevalent species (20.7%), followed by MH (13.4%), MG (5.7%), and UP (3.2%); 67.3% of the positive samples would have been missed if only urethral samples had been taken. Receptive anal sex (prevalence ratio [PR] = 1.79; 95% CI = 1.07-3.01) and clinical suspicion of sexually transmitted infection (PR = 1.62; 95% CI = 1.01-2.61) were factors associated with the detection of Mollicutes in general. Group sex (PR = 1.98; 95% CI = 1.12-3.50) and receptive anal sex (PR = 2.36; 95% CI = 0.95-5.86) were associated with the detection of Mycoplasma spp. No sociodemographic, clinical, or behavioural variable was significantly associated with the detection of Ureaplasma spp. A high prevalence of Mollicutes was observed among adolescent MSM and TGW, especially at extragenital sites. Further research is required to understand the epidemiological profile of high-risk adolescents in different regions and contexts, and to investigate the pathogenesis of Mollicutes in the oral and anal mucosa before routine screening can be recommended in clinical practice.
Sections du résumé
BACKGROUND
BACKGROUND
Some species of Mollicutes have been associated with different pathologies of the urogenital tract in humans, with a high prevalence among adult men who have sex with men (MSM) and transgender women (TGW). However, few studies have been performed to investigate its prevalence among adolescents. In this study, we estimated the initial prevalence of Mycoplasma genitalium (MG), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), and Ureaplasma parvum (UP); the rate of misdiagnosis at different anatomical sites; and the associated factors with positive tests for Mollicutes among MSM and TGW aged 15 to 19 years enrolled in the PrEP1519 study.
METHODS
METHODS
PrEP-1519 is the first study to investigate the effectiveness of pre-exposure prophylaxis for human immunodeficiency virus among adolescent MSM and TGW aged 15 to 19 in Latin America. Oral, anal, and urethral swabs were taken from 246 adolescents upon enrolment in the study to detect MG, MH, UU, and UP by quantitative polymerase chain reaction (qPCR). Bivariate and multivariate analyses were conducted by Poisson regression and 95% confidence intervals (95% CI) were estimated.
RESULTS
RESULTS
The prevalence of Mollicutes was 32.1%. UU was the most prevalent species (20.7%), followed by MH (13.4%), MG (5.7%), and UP (3.2%); 67.3% of the positive samples would have been missed if only urethral samples had been taken. Receptive anal sex (prevalence ratio [PR] = 1.79; 95% CI = 1.07-3.01) and clinical suspicion of sexually transmitted infection (PR = 1.62; 95% CI = 1.01-2.61) were factors associated with the detection of Mollicutes in general. Group sex (PR = 1.98; 95% CI = 1.12-3.50) and receptive anal sex (PR = 2.36; 95% CI = 0.95-5.86) were associated with the detection of Mycoplasma spp. No sociodemographic, clinical, or behavioural variable was significantly associated with the detection of Ureaplasma spp.
CONCLUSIONS
CONCLUSIONS
A high prevalence of Mollicutes was observed among adolescent MSM and TGW, especially at extragenital sites. Further research is required to understand the epidemiological profile of high-risk adolescents in different regions and contexts, and to investigate the pathogenesis of Mollicutes in the oral and anal mucosa before routine screening can be recommended in clinical practice.
Identifiants
pubmed: 37072756
doi: 10.1186/s12879-023-08213-z
pii: 10.1186/s12879-023-08213-z
pmc: PMC10114492
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
244Subventions
Organisme : AIDS Healthcare Foundation
ID : 2017-15-FIOTECPrEP
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 404055/2018-4
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 409828/2018-1
Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
ID : Code 001
Informations de copyright
© 2023. The Author(s).
Références
Sex Transm Dis. 2017 Aug;44(8):457-462
pubmed: 28703723
Appl Environ Microbiol. 1994 Jan;60(1):149-52
pubmed: 7509584
Br J Obstet Gynaecol. 1996 Nov;103(11):1124-8
pubmed: 8917001
Health Care Women Int. 2015;36(8):917-35
pubmed: 24588138
J Neurosci. 2006 Jun 21;26(25):6885-92
pubmed: 16793895
Sex Transm Dis. 2019 Nov;46(11):737-742
pubmed: 31453926
J Sch Health. 1992 Sep;62(7):331-8
pubmed: 1434562
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1845-1851
pubmed: 29924422
Urology. 2017 Feb;100:97-102
pubmed: 27871827
Int J STD AIDS. 2016 Sep;27(10):861-7
pubmed: 26378187
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):1-10
pubmed: 21808429
Lancet. 2015 Jan 17;385(9964):274-86
pubmed: 25059941
Int J STD AIDS. 2009 Jun;20(6):387-90
pubmed: 19451322
J Microbiol Immunol Infect. 2018 Dec;51(6):778-783
pubmed: 28739435
BMC Microbiol. 2008 Jul 29;8:130
pubmed: 18664269
Clin Microbiol Infect. 2016 Mar;22(3):260-5
pubmed: 26686807
Acta Derm Venereol. 2010 Sep;90(5):461-7
pubmed: 20814619
J Int AIDS Soc. 2020 Oct;23 Suppl 6:e25599
pubmed: 33000907
Lancet. 1981 Jun 13;1(8233):1288-91
pubmed: 6112607
Int J STD AIDS. 2014 Jun;25(7):465-74
pubmed: 24352129
Sex Transm Infect. 2010 Feb;86(1):21-4
pubmed: 19843536
Arch Sex Behav. 2020 Aug;49(6):1995-2003
pubmed: 32500245
AIDS Behav. 2020 Jun;24(6):1966-1975
pubmed: 31858300
Clin Infect Dis. 2005 Jul 1;41(1):67-74
pubmed: 15937765
J Assoc Nurses AIDS Care. 2009 Sep-Oct;20(5):348-61
pubmed: 19732694
Curr Opin Infect Dis. 2014 Feb;27(1):68-74
pubmed: 24322592
Sex Transm Infect. 2020 Jun;96(4):300-305
pubmed: 31451540
AIDS Behav. 2020 Mar;24(3):938-950
pubmed: 30879210
Clin Infect Dis. 2017 Feb 1;64(3):250-256
pubmed: 28011607
Sex Health. 2013 Jul;10(3):199-203
pubmed: 23751932
BMC Int Health Hum Rights. 2019 Mar 5;19(1):8
pubmed: 30832659
Int J STD AIDS. 2016 Oct;27(11):928-37
pubmed: 27147267
BMC Infect Dis. 2020 Feb 7;20(1):110
pubmed: 32033533
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18715
pubmed: 24242263
Int J STD AIDS. 2017 Jun;28(7):708-714
pubmed: 27542698
Boll Ist Sieroter Milan. 1981;60(1):31-40
pubmed: 7272010
Clin Infect Dis. 2011 Dec;53 Suppl 3:S129-42
pubmed: 22080266
Sex Transm Infect. 2004 Aug;80(4):289-93
pubmed: 15295128
Health Promot Int. 2016 Mar;31(1):133-43
pubmed: 25381163
Int J STD AIDS. 2012 Jun;23(6):455-6
pubmed: 22807547
Sex Transm Infect. 2020 Feb;96(1):10-18
pubmed: 31217322
JAC Antimicrob Resist. 2021 Jun 30;3(2):dlab091
pubmed: 34223146
Dev Sci. 2007 Mar;10(2):F8-F14
pubmed: 17286837
J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1650-1656
pubmed: 27505296
AIDS Behav. 2017 Oct;21(10):3026-3034
pubmed: 28702851
Int J Health Serv. 2020 Jan;50(1):44-61
pubmed: 31684808
J Korean Med Sci. 2017 Nov;32(11):1771-1778
pubmed: 28960028
PLoS One. 2018 Apr 11;13(4):e0194306
pubmed: 29641528
Sex Transm Infect. 2018 Sep;94(6):406-410
pubmed: 29567802
AIDS Behav. 2018 May;22(5):1662-1670
pubmed: 29168069
BMC Int Health Hum Rights. 2016 Jan 14;16:2
pubmed: 26769484
Transgend Health. 2020 Jun 08;5(2):90-103
pubmed: 32656353
Curr Opin Pediatr. 2018 Feb;30(1):137-143
pubmed: 29315111
J Clin Microbiol. 2006 Jun;44(6):2078-83
pubmed: 16757601
Cien Saude Colet. 2020 May;25(5):1723-1734
pubmed: 32402024
Sex Transm Dis. 2004 Mar;31(3):192-5
pubmed: 15076934
Sex Transm Infect. 2014 Nov;90(7):545-9
pubmed: 24687129
Clin Infect Dis. 2009 Dec 15;49(12):1793-7
pubmed: 19911970
Clin Infect Dis. 2018 Mar 5;66(6):936-944
pubmed: 29069298
Microbiology (Reading). 2020 Jan;166(1):21-29
pubmed: 31329090
PLoS One. 2014 Dec 02;9(12):e113771
pubmed: 25463970
Int J STD AIDS. 2000 May;11(5):284-7
pubmed: 10824935
Emerg Infect Dis. 2019 Apr;25(4):719-727
pubmed: 30882306
Acta Med Port. 2018 May 30;31(5):247-253
pubmed: 29916355
Andrology. 2015 Sep;3(5):809-16
pubmed: 26311339
AIDS. 2012 Mar 13;26(5):617-24
pubmed: 22210630
BMC Infect Dis. 2017 Dec 15;17(1):769
pubmed: 29246195
Rev Cienc Soc. 2013 Summer-Winter;26:50-59
pubmed: 25678720
Rev Esc Enferm USP. 2012 Jun;46(3):711-9
pubmed: 22773494
BMC Infect Dis. 2019 Jun 4;19(1):494
pubmed: 31164096
J Acquir Immune Defic Syndr. 2012 May 1;60(1):83-90
pubmed: 22522237
Clin Infect Dis. 2014 Jun;58(11):1564-70
pubmed: 24647015
BMJ Open. 2017 Jul 10;7(7):e016300
pubmed: 28698342